Découvrez les Meilleures Cliniques et Coûts pour Votre Une greffe de moelle osseuse en Thaïlande en 2026

Bone marrow transplantation success rates in Thailand range from 75% to 96% for most patients. Specialized centers like Bumrungrad International Hospital report one-year survival rates between 92% and 96%. These outcomes align with international benchmarks for malignant and non-malignant blood disorders.

• Non-malignant disorders: Thalassemia and aplastic anemia often see success rates exceeding 80–90%.
• Pediatric leukemia: Leading Thai hospitals report five-year survival rates reaching 92–94%.
• Donor matching: Matched sibling donors yield 70–90% success, while half-matched donors reach 60–80%.
• Center experience: Bumrungrad International Hospital has performed over 1,500 transplants with high success.

Bookimed Expert Insight: Thai centers like Bumrungrad achieve Western-level success partly due to their massive international volume. With 50% of patients coming from 190 countries, surgeons like Dr. Surasit Issarachai manage diverse genetic profiles. This high-volume exposure often results in more refined protocols for complex graft-versus-host disease (GVHD) management.

Patient Consensus: Patients report high satisfaction with the 18-month post-transplant survival window. They emphasize that while clinical success is high, physical recovery takes a full year.

Bone marrow transplantation in Thailand is safe and reliable for international patients at JCI-accredited facilities like Bumrungrad International Hospital. These centers maintain success rates of 80-90% for conditions like leukemia, utilizing HEPA-filtered isolation rooms and specialists certified by the Thai Board of Hematology to ensure rigorous infection control.

• Global accreditation: Top hospitals hold Joint Commission International and Global Healthcare Accreditation for medical tourism.
• Specialist expertise: Physicians like Dr. Surasit Saleh Issarachai at Bumrungrad provide expert oncohematology care.
• Advanced infrastructure: Facilities use laminar airflow and 24/7 monitoring to prevent post-transplant infections.
• Registry access: Thai centers coordinate with the World Marrow Donor Association for international matching.

Bookimed Expert Insight: While Thailand is famous for medical tourism, its bone marrow transplant infrastructure is highly concentrated. Bumrungrad International Hospital alone manages over 1 million patients annually with 50% being international. This high volume of foreign cases means their administrative teams are uniquely experienced in managing the complex 3-6 month medical visas required for BMT recovery.

Patient Consensus: Patients emphasize that while clinical care is world-class, success depends on staying in Bangkok for 3-6 months. Most recommend budgeting extra for visa extensions and local housing to ensure safe monitoring for complications like Graft-versus-Host Disease.

The best hospitals for bone marrow transplantation in Thailand include JCI-accredited facilities like Bumrungrad International Hospital and Samitivej Sukhumvit. These centers specialize in complex allogenic and haploidentical transplants, offering advanced HEPA-filtered units, international patient support, and success rates reaching 85% for hematologic conditions.

• Bumrungrad International: Features AI-driven diagnostics and specialized haploidentical transplant programs for half-matched donors.
• Samitivej Sukhumvit: Recognized for pediatric BMT expertise and advanced photopheresis treatments for GvHD.
• Vejthani Hospital: Holds JCI accreditation and provides comprehensive autologous transplant services for oncology patients.
• Public university centers: Siriraj and King Chulalongkorn hospitals offer deep academic research and affordability.

Bookimed Expert Insight: While private hospitals like Bumrungrad serve 50% international patients, their primary advantage is the lack of wait times. Dr. Surasit Saleh Issarachai at Bumrungrad manages high-volume cases that rival global centers. Patients should prioritize clinics with GHA accreditation to ensures seamless logistics for the long-term recovery BMT requires.

Patient Consensus: Seeking JCI-accredited hospitals is essential for managing BMT logistics and English communication. Many patients recommend confirming donor matching capabilities through virtual consultations before traveling to Bangkok.

Patients typically stay in the hospital for 3 to 6 weeks following a bone marrow transplant in Thailand. This window allows for pre-transplant conditioning, the infusion procedure, and critical monitoring until your new stem cells begin producing healthy blood cells, a process known as engraftment.

• Transplant type: Autologous stays average 2 to 3 weeks; allogeneic often requires 4 or more weeks.
• Engraftment milestone: Discharge usually occurs 15 to 30 days after cells begin producing enough white blood cells.
• Medical stability: Patients must remain fever-free for 48 hours and tolerate oral medications before leaving.
• Post-discharge monitoring: Plan to remain in Bangkok for 1 to 3 months for frequent outpatient checks.

Bookimed Expert Insight: While a 3-week stay is standard, data from JCI-accredited centers like Bumrungrad reveals that engraftment happens faster in autologous cases. Some patients successfully move to nearby hotels by day 14. However, you should budget for 30% additional time since secondary infections often require short-term readmissions for IV antibiotics.

Patient Consensus: Expect to spend 2 months in Thailand total. Many find they can leave the hospital around day 21 but require daily blood draws and local isolation for several weeks afterward.

Locating a bone marrow donor in Thailand involves a systematic search starting with biological siblings for a full HLA match. If unavailable, hospitals like Bumrungrad International Hospital utilize the Thai National Stem Cell Donor Registry and global databases through the World Marrow Donor Association.

• Familial testing: Biological siblings provide a 25% chance of a perfect 100% HLA match.
• Haploidentical donation: Parents or children often serve as 50% matches in advanced Thai facilities.
• Local registry: The Thai Red Cross Society manages approximately 100,000 predominantly Thai donors locally.
• Global search: JCI-accredited centers access international registries if no local donor is identified.

Bookimed Expert Insight: Thai hospitals like Bumrungrad International often bypass long registry waits by using haploidentical transplants. Their expertise with 50% matches allows patients to find donors within their own family quickly. This specialized approach significantly reduces the search time compared to waiting for an unrelated international donor.

Patient Consensus: Patients recommend starting family HLA typing early to avoid the 8-week logistical delays common with international donor imports. Many suggest checking ethnic background compatibility upfront as local registries have high success for Thai and Asian patients.

Recovery after bone marrow transplantation in Thailand follows a three-phase timeline. Patients typically spend 3 to 6 weeks in specialized isolation units for engraftment. While initial physical recovery takes approximately 3 months, full immune system restoration generally requires 12 to 24 months of careful monitoring.

• Immediate phase: Hospitalization lasts 21 to 40 days until new stem cells begin producing blood.
• Engraftment window: New cell growth typically occurs between day 10 and day 28 post-transplant.
• Intermediate recovery: Patients transition to outpatient care with weekly blood monitoring for 100 days.
• Long-term restoration: Energy levels improve significantly by month 6, though vaccinations start after 1 year.

Bookimed Expert Insight: While recovery stages are universal, Thailand clinics like Bumrungrad International Hospital offer high-tech isolation rooms that simplify the first 30 days. These JCI-accredited facilities use advanced HEPA filtration which is critical in tropical climates. Choosing a center with specialized oncohematologists like those at Intrarat Hospital ensures tight monitoring for graft-versus-host disease during the high-risk 100-day window.

Patient Consensus: Many survivors describe the first month as a period of intense fatigue often confined to bed. Most patients report reaching 50% of their normal activity levels by the 6-month mark.